 AstraZeneca said it has agreed to buy CinCor Pharma, maker of clinical-stage blood pressure drug baxdrostat, in a deal valued at 1.8 billion. The post AstraZeneca To Acquire Blood-Pressure Drugmaker In 1.8 Billion Deal appeared first on Investors Business Daily. 